Does ELOSULFASE ALFA Cause Dyspnoea? 216 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 216 reports of Dyspnoea have been filed in association with ELOSULFASE ALFA (VIMIZIM). This represents 4.3% of all adverse event reports for ELOSULFASE ALFA.
216
Reports of Dyspnoea with ELOSULFASE ALFA
4.3%
of all ELOSULFASE ALFA reports
13
Deaths
97
Hospitalizations
How Dangerous Is Dyspnoea From ELOSULFASE ALFA?
Of the 216 reports, 13 (6.0%) resulted in death, 97 (44.9%) required hospitalization, and 14 (6.5%) were considered life-threatening.
Is Dyspnoea Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ELOSULFASE ALFA. However, 216 reports have been filed with the FAERS database.
What Other Side Effects Does ELOSULFASE ALFA Cause?
Pyrexia (682)
Cough (318)
Vomiting (308)
Malaise (282)
Headache (242)
Nausea (212)
Pain (205)
Nasopharyngitis (183)
Fatigue (177)
Product dose omission (155)
What Other Drugs Cause Dyspnoea?
ALBUTEROL (21,856)
TREPROSTINIL (16,348)
AMBRISENTAN (13,367)
PREDNISONE (12,830)
BUDESONIDE\FORMOTEROL (11,158)
TIOTROPIUM (10,863)
ADALIMUMAB (10,547)
DUPILUMAB (10,310)
FLUTICASONE\SALMETEROL (9,783)
MEPOLIZUMAB (9,192)
Which ELOSULFASE ALFA Alternatives Have Lower Dyspnoea Risk?
ELOSULFASE ALFA vs ELOTUZUMAB
ELOSULFASE ALFA vs ELOXATIN
ELOSULFASE ALFA vs ELRANATAMAB
ELOSULFASE ALFA vs ELRANATAMAB-BCMM
ELOSULFASE ALFA vs ELTROMBOPAG